Sutro Biopharma logo

Sutro Biopharma

STRO | NASDAQ
Chart Builder DCF Calculator
$9.32
-$0.50 (-5.09%)
At close: Nov 16, 2026, 4:00 PM ET
$9.32
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-5.09%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
37.8
+4.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #589/1021 (Top 58%)

Key Statistics

Market Data

Market Cap $154.73M
1D Range
8.34 9.64
52W Range
7.30 40.91

Valuation (TTM)

PE -0.74
PB -1.17
EV/EBITDA -2.47

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $50.00
Loading financial charts...

Profile

Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-...

Sector Healthcare
Industry Biotechnology
Employees 128
IPO Date Sep 27, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$1.9
Miss -15.85%
REV
$9.1M
Miss -35.50%
Next Earnings
Mar 22, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
6
Consensus
Buy
Price Target
$50.00
Upside
+436.48%
Buy (6)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.